Wesana Health Holdings Stock Today
| WSNAF Stock | USD 0 0 28.33% |
Performance9 of 100
| Odds Of DistressOver 77
|
Wesana Health is trading at 0.0043 as of the 2nd of December 2024. This is a 28.33 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0043. Wesana Health has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Wesana Health Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 13th of December 2022 and ending today, the 2nd of December 2024. Click here to learn more.
Wesana Health Holdings Inc, a life sciences company, engages in the development and delivery of psychedelic medicines and psilocybin-assisted psychotherapies to treat traumatic brain injuries. It is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company has 20.49 M outstanding shares. More on Wesana Health Holdings
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Wesana Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Wesana Health Holdings [WSNAF] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 690.66 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Wesana Health's market, we take the total number of its shares issued and multiply it by Wesana Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Wesana Health Holdings classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 20.49 M outstanding shares.
Wesana Health Holdings has accumulated about 1.77 M in cash with (11.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Wesana Health Probability Of Bankruptcy
Ownership AllocationWesana Health Holdings retains a total of 20.49 Million outstanding shares. Wesana Health Holdings maintains 4.64 (%) of its outstanding shares held by insiders and 13.77 (%) owned by institutional investors. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Wesana Ownership Details
Wesana Health Holdings Risk Profiles
| Mean Deviation | 25.44 | |||
| Semi Deviation | 22.45 | |||
| Standard Deviation | 35.84 | |||
| Variance | 1284.73 |
Wesana Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Wesana Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Wesana Health Corporate Management
| Daniel Carcillo | CEO CoFounder | Profile | |
| Jeffrey Jewell | VP Affairs | Profile | |
| Zed Wang | CFO Sec | Profile | |
| Mark Wingertzahn | Chief Officer | Profile | |
| Chad Bronstein | CoFounder | Profile | |
| Keenan Gentry | VP Devel | Profile | |
| Izzy Forman | VP Communications | Profile |
Other Information on Investing in Wesana Pink Sheet
Wesana Health financial ratios help investors to determine whether Wesana Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Wesana with respect to the benefits of owning Wesana Health security.